Regeneron Pharmaceuticals (REGN)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:299
% of all portfolios:0.136%
Hold Price * :$772.64
History Portfolio Manager Activity Share change % change to portfolio ▲
Q1  2026
≡ Dodge & Cox Funds Reduce 3.00% 138,120 0.06
≡ Harry Burn - Sound Shore Reduce 14.17% 24,927 0.65
≡ Mason Hawkins - Southeastern Asset Management Reduce 21.19% 35,130 1.34
Q3  2025
≡ Mason Hawkins - Southeastern Asset Management Reduce 9.95% 15,974 0.46
≡ Michael Burry - Scion Asset Management Sell 100.00% 15,000 14.00
Q2  2025
≡ Viking Global Investors Sell 100.00% 97,739 0.20
Q4  2024
≡ Viking Global Investors Sell 100.00% 49,870 0.19
Q3  2024
≡ Dodge & Cox Funds Reduce 0.16% 3,751 0.00
Q2  2024
≡ Dodge & Cox Funds Reduce 1.87% 44,178 0.03
Q1  2024
≡ Lee Ainslie - Maverick Capital Sell 100.00% 1,758 0.03
Q1  2023
≡ Thomas Gayner - Markel Group Sell 100.00% 30,500 0.30
Q4  2022
≡ Thomas Gayner - Markel Group Reduce 62.02% 49,800 0.49
Q2  2022
≡ Polen Capital Management Sell 100.00% 1,383 0.00
Q1  2022
≡ Polen Capital Management Reduce 28.64% 555 0.00
Q4  2021
≡ Lee Ainslie - Maverick Capital Sell 100.00% 490 0.00
≡ Polen Capital Management Reduce 10.07% 217 0.00
Q1  2021
≡ Polen Capital Management Sell 100.00% 2,002,804 2.25
Q4  2020
≡ Lee Ainslie - Maverick Capital Sell 100.00% 588 0.01
Q2  2019
≡ Polen Capital Management Reduce 1.09% 17,448 0.03
Q1  2011
≡ Seth Klarman - Baupost Group Sell 100.00% 1,000,000 1.96
Q2  2009
≡ Bill & Melinda Gates Foundation Trust Sell 100.00% 35,500 0.01

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.